Health Discovery appoints Dr. Alan Hauser as CEO, replacing George McGovern

HEALTH DISCOVERY CORP

Dr. Alan Hauser appointed CEO effective July 8, 2024, replacing former CEO George McGovern.
Compensation includes $180K base salary and 1,000,000 restricted shares vesting July 8, 2025.
Performance-based grants: 500K shares upon 6 months and 500K shares upon 12 months of employment.
Hauser previously CEO of Arvetas Biosciences (2020-2024), focused on machine learning and precision medicine.
Board cites his plan to evaluate IP, find commercial opportunities, and meet IRS/SEC requirements.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Alan K. Hauser

Chief Executive Officer

HEALTH DISCOVERY CORP

Effective: 2024-07-08
Filed: July 11, 2024, 7:59 PM ET

On July 8, 2024, Dr. Alan K. Hauser, Ph.D. was appointed as Chief Executive Officer of Health Discovery Corporation

Departed

George McGovern

Chief Executive Officer

HEALTH DISCOVERY CORP

Effective: 2024-07-08
Successor: Dr. Alan K. Hauser
Filed: July 11, 2024, 7:59 PM ET

Following an extensive search, the Board of Directors hired Dr. Hauser to replace George McGovern, the former Chief Executive Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Alan K. Hauser was appointed as Chief Executive Officer at HEALTH DISCOVERY CORP.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On July 8, 2024, Dr. Alan K. Hauser, Ph.D. was appointed as Chief Executive Officer of Health Discovery Corporation

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

George McGovern departed as Chief Executive Officer at HEALTH DISCOVERY CORP.

Action: replaced
Role: Chief Executive Officer

Exact text from the filing

Following an extensive search, the Board of Directors hired Dr. Hauser to replace George McGovern, the former Chief Executive Officer of the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001683168-24-004754

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.